Risk of Developing Low-Level Viral Rebound Among People With HIV Receiving 2- or 3-Drug Regimens: A Case-Control Study Nested in the ICONA Cohort Alessandra Vergori, Adriana Cervo, Ashley Roen, Roberta Gagliardini, Tommaso Clemente, Valentina Mazzotta, Eugenia Quiros-Roldan, Franco Maggiolo, Sergio Lo Caputo, Cristina Mussini, Andrea Antinori, Alessandro Cozzi-Lepri, ICONA Foundation Study, A d'Arminio Monforte, A Antinori, S Antinori, A Castagna, M Cernuschi, L Cosmaro, A Di Biagio, E Dibrino, E Girardi, S Lo Caputo, G C Marchetti, C Mussini, E Quiros-Roldan, L Sarmati, B Suligoi, C Torti, A d’Arminio Monforte, A Antinori, A Castagna, F Ceccherini-Silberstein, A Cingolani, A Cozzi-Lepri, A Di Biagio, R Gagliardini, A Giacomelli, E Girardi, A Gori, S Lo Caputo, G Marchetti, F Maggiolo, C Mussini, M Puoti, C F Perno, A Tavelli, A Antinori, A Bandera, S Bonora, A Calcagno, A Castagna, F Ceccherini-Silberstein, A Cervo, A Cingolani, P Cinque, A Cozzi-Lepri, A d’Arminio Monforte, A De Vito, A Di Biagio, A Fortunato, R Gagliardini, A M Geretti, A Giacomelli, E Girardi, N Gianotti, A Gori, G Guaraldi, S Lanini, G Lapadula, M Lichtner, A Lai, S Lo Caputo, G Madeddu, F Maggiolo, V Malagnino, I Mastrorosa, G Marchetti, A Mondi, V Mazzotta, C Muccini, C Mussini, S Nozza, C F Perno, S Piconi, C Pinnetti, M C Poliseno, M Puoti, E Quiros Roldan, R Rossotti, S Rusconi, M M Santoro, A Saracino, L Sarmati, V Spagnuolo, N Squillace, V Svicher, L Taramasso, C Tincati, C Torti, A Vergori, A Cozzi-Lepri, S De Benedittis, I Fanti, M Giotta, S Lanini, N Lentini, M Muccio, R Pastorino, A Rodano’, A Roen, A Tavelli, S Bazzichetto, M Cernuschi, L Cosmaro, A Perziano, V Calvino, D Russo, M Farinella, N Policek, V L Del Negro, S Carrara, S Graziano, G Prota, H Sadeghi, V Sala, S Truffa, D Vincenti, R Rovito, A Giacometti, A Costantini, V Barocci, A Saracino, C Santoro, E Milano, L Comi, D Valenti, P Viale, A Zupparoli, S Cretella, E M Erne, A Pieri, E Quiros Roldan, E Focà, S Minniti, B Menzaghi, C Abeli, L Chessa, F Pes, C Sagnelli, L Alessio, G Nunnari, B M Celesia, J Vecchiet, K Falasca, A Pan, S Dal Zoppo, D Segala, A Bartoloni, B Borchi, C Costa, A Castellaccio, S Lo Caputo, A Narducci, M Bassetti, E Pontali, S Blanchi, N Bobbio, C Del Borgo, R Marocco, G Mancarella, S Piconi, C Molteni, S Rusconi, G Canavesi, P Colletti, G Pellicanò, Y Russotto, G Marchetti, S Antinori, A Gori, M Puoti, A Castagna, A Bandera, G Bozzi, M V Cossu, V Iannone, R Lolatto, M C Moioli, G Carrozzo, N Capra, M Augello, D Moschese, C Mussini, M Menozzi, P Bonfanti, G Lapadula, I Gentile, V Esposito, R Viglietti, N Coppola, F M Fusco, G Di Filippo, V Rizzo, N Sangiovanni, S Martini, A M Cattelan, B Bragato, A Cascio, C Iaria, M Trizzino, R Gulminetti, G De Socio, E Schiaroli, G Parruti, F Sozio, D Messeri, S I Bonelli, C Lazzaretti, R Corsini, A Antinori, C Torti, G D’Ettorre, L Sarmati, A Latini, A Cingolani, G Micheli, S Lamonica, M Capozzi, M Camici, I Mezzaroma, M Rivano Capparuccia, G Iaiani, C Stingone, L Gianserra, J Paulicelli, M M Plazzi, L Bortolani, M Fusto, G Madeddu, G Moi, M Fabbiani, F Montagnani, A Franco, R Fontana Del Vecchio, C Ucciferri, C Di Giuli, G C Orofino, G Calleri, G Di Perri, S Bonora, D Meloni, C Tascini, M Cotrufo, G Battagin, S Nicolè, G Starnini, S Dell’Isola Open Forum Infectious Diseases, 2026 Background The risk of developing low-level viral rebound (LLVR) after achieving human immunodeficiency virus HIV-1 (HIV) RNA suppression with 2-drug regimens (2DR) compared to 3-drug regimens (3DR) remains uncertain. Methods We conducted a matched 1:3 case-control study nested within the ICONA cohort including persons with HIV (PWH) who achieved virological suppression (≥2 consecutive HIV-RNA ≤50 copies/mL over 6 months) after 11 November 2014 (baseline [BL]). Cases were defined as PWH experiencing a single HIV-RNA of 51–199 copies/mL after BL (index date); controls were defined as those who maintained HIV-RNA ≤50 copies/mL up to the index date and were matched for history of care gaps and number of drugs failed. The cumulative incidence of LLVR after virological suppression was estimated using Kaplan–Meier methods, and conditional logistic regression models were used to evaluate the association between the current antiretroviral therapy regimen (2DR [dolutegravir/lamivudine, dolutegravir/rilpivirine, dolutegravir/doravirine, or cabotegravir/rilpivirine] vs 3DR [dolutegravir, bictegravir, rilpivirine, doravirine, boosted darunavir, or boosted atazanavir–based with a backbone of tenofovir and lamivudine or emtricitabine]) and LLVR risk. In sensitivity analyses cases were defined as PWH experiencing 2 consecutive HIV-RNA of 51–199 copies/mL. Results Among 1033 PWH (261 cases, 772 matched controls), 21% were female, median age was 43 (interquartile range [IQR], 34–51) years, and BL CD4 count was 601 (IQR, 379–826) cells/μL; 2DR use was 25% in cases versus 29% in controls (P = .23). Two years after viral suppression, cumulative LLVR incidence was 2.7% (95% CI, 2.3%–3.1%) when considering single LLVR events and 1.8% (95% CI, 1.4%–2.1%) when limited to 2 consecutive values. After adjusting for confounding, evidence for an association with current regimen was inconclusive (adjusted odds ratio, 0.86 [95% CI, .57–1.29]). Conclusions Despite the wide range of plausibility, we can exclude a risk of LLVR higher than 29% when using 2DR versus 3DR regimens.
Effectiveness of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide from Rilpivirine or Other Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Based Antiretroviral Therapy in Virologically Suppressed People with HIV: A Retrospective Analysis (DRIVE-SWITCH Study) Roberta Gagliardini, Alessandro Caioli, Marisa Fusto, Sandrine Ottou, Federica Forbici, Lavinia Fabeni, Fabrizio Maggi, Maria Maddalena Plazzi, Federico De Zottis, Rita Bellagamba, Jessica Paulicelli, Ilaria Mastrorosa, Elisabetta Grilli, Carmela Pinnetti, Valentina Mazzotta, Roberto Caldera, Gabriele Forcina, Andrea Antinori Infectious Diseases and Therapy, 2026 INTRODUCTION: Extensive real-world data in people with HIV (PWH) switching from non-nucleoside reverse transcriptase inhibitors (NNRTIs), in particular from rilpivirine (RPV)-based regimens to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF), are lacking. METHODS: This is a single-center retrospective study. Inclusion criteria were PWH aged ≥ 18 years, virologically suppressed on NNRTI triple antiretroviral regimens. The primary endpoint was the proportion of PWH with HIV-RNA < 50 cp/mL at 12 months from time of switch to B/F/TAF. RESULTS: Overall, 214 PWH were included, of whom 105 (49.1%) were switching from RPV/FTC/TAF. After 12 months, the proportion of PWH with HIV-RNA < 50 copies/mL was 82.7% (95% confidence interval, CI, 77.1-87.2) at intention-to-treat (ITT) and 95.7% (95% CI 91.7-97.8) at missing=excluded (M=E) analysis. In the group switching from RPV/FTC/TAF, the proportion of PWH with HIV-RNA < 50 copies/mL at 12 months was 74.3% (95% CI 65.2-81.7) at ITT and 95.1% (95% CI 88.1-98.1) at M=E analysis. Two PWH (0.93%, 95% CI 0.26-3.34) experienced virological failure after switching to B/F/TAF, with no resistance mutations detected. Six treatment discontinuations were observed (2.8%, 95% CI 1.3-5.6). A decrease in low-density lipoprotein (LDL) cholesterol was documented when switching from RPV/FTC/TAF to B/F/TAF. CONCLUSION: Switching to B/F/TAF from NNRTI-based regimens, particularly if RPV-based, showed high virological effectiveness and rare treatment discontinuations. No resistance mutations were detected at failure.
Peer-supported digital collection of patient-reported outcomes in HIV care: Promise, practical barriers and lessons from a pilot study within the ICONA cohort S. De Benedittis, A. Tavelli, R. Gagliardini, T. Bini, M. Guastavigna, V. Mazzotta, C. Muccini, M. Farinella, L. Cosmaro, A. Perziano, G. Guaraldi, A. Cozzi‐Lepri, A. Giacomelli, M. Cernuschi, A. d' Arminio Monforte, A. Cingolani, and HIV Medicine, 2026 Purpose To explore whether peer support could enhance patient‐reported outcome (PRO) completion through a mobile health platform within the ICONA cohort of people with HIV in Italy, and to identify practical lessons for integrating peers into digital, person‐centred HIV care. Materials and Methods A pilot intervention was implemented in four cohort centres where trained peers, affiliated with the ICONA Community Advisory Board, supported PRO completion using the e‐QoL mobile app over a five‐month period. Fourteen additional centres without peer involvement served as comparisons. The primary outcome was the proportion of people with HIV fully completing ≥1 PRO before and during the intervention. A Difference‐in‐Difference (DiD) model, adjusted for demographic, HIV‐related and socioeconomic variables, estimated the effect of the peer intervention. Results During the intervention, 2421 people with HIV were followed in peer‐supported centres and 2640 in peer‐free centres. PRO completion increased from 1.24% to 3.08% in peer‐supported sites, while a slight decline was observed in comparison centres (0.97% to 0.83%). The adjusted DiD analysis indicated a 2.0% absolute increase (95% CI: −0.40 to 4.5) attributable to peer support. Respondents were predominantly cisgender Italian men with higher education, suggesting limited reach to more digitally or socially vulnerable groups. Conclusion Peer support modestly improved PRO completion and fostered greater awareness of PROs within HIV care.
Did the COVID-19 pandemic shift the landscape of late HIV diagnosis? Giulia Micheli, Annalisa Mondi, Ashley Roen, Lucia Taramasso, Ilenia Luchetti, Valentina Mazzotta, Giulia Marchetti, Loredana Sarmati, Andrea Gori, Giuseppe Lapadula, Cristina Mussini, Antonella D'Arminio Monforte Monforte, Enrico Girardi, Alessandro Cozzi-Lepri, Andrea Antinori, A d’Arminio Monforte, A Antinori, S Antinori, A Castagna, R Cauda, G Di Perri, E Girardi, R Iardino, A Lazzarin, GC Marchetti, C Mussini, E Quiros-Roldan, L Sarmati, B Suligoi, F von Schloesser, P Viale, F Ceccherini-Silberstein, A Cingolani, A Cozzi-Lepri, A Di Biagio, A Gori, S Lo Caputo, G Marchetti, F Maggiolo, M Puoti, CF Perno, C Torti, A Bandera, S Bonora, A Calcagno, D Canetti, A Cervo, P Cinque, R Gagliardini, A Giacomelli, N Gianotti, G Guaraldi, S Lanini, G Lapadula, M Lichtner, A Lai, G Madeddu, V Malagnino, A Mondi, V Mazzotta, S Nozza, S Piconi, C Pinnetti, E Quiros Roldan, R Rossotti, S Rusconi, MM Santoro, A Saracino, V Spagnuolo, N Squillace, V Svicher, L Taramasso, A Vergori, S De Benedittis, I Fanti, M Giotta, N Lentini, C Marelli, R Pastorino, A Rodano’, A Tavelli, S Bazzichetto, M Cernuschi, L Cosmaro, A Perziano, V Calvino, D Russo, M Farinella, N Policek, VL Del Negro, M Augello, S Carrara, S Graziano, G Prota, S Truffa, D Vincenti, R Rovito, A Giacometti, A Costantini, V Barocci, C Santoro, E Milano, L Comi, C Suardi, L Badia, S Cretella, EM Erne, A Pieri, E Focà, B Menzaghi, C Abeli, L Chessa, F Pes, P Maggi, L Alessio, G Nunnari, BM Celesia, J Vecchiet, K Falasca, A Pan, S Dal Zoppo, D Segala, F Bartalesi, A Bartoloni, B Borchi, C Costa, S Ferrara, M Bassetti, E Pontali, S Blanchi, N Bobbio, C. Del Borgo, R. Marocco, G. Mancarella, C Molteni, G Canavesi, G Pellicanò, Y Russotto, V Bono, MV Cossu, R Lolatto, MC Moioli, L Pezzati, S Diotallevi, C Tincati, M Menozzi, P Bonfanti, V Sangiovanni, I Gentile, V Esposito, N Coppola, FM Fusco, G Di Filippo, V Rizzo, N Sangiovanni, S Martini, AM Cattelan, D Leoni, A Cascio, M Trizzino, D Francisci, E Schiaroli, G Parruti, F Sozio, D Messeri, SI Bonelli, C Lazzaretti, R Corsini, C Mastroianni, A Latini, I Mastrorosa, S Lamonica, M Capozzi, M Camici, I Mezzaroma, M Rivano Capparuccia, G Iaiani, C Stingone, L Gianserra, J Paulicelli, MM Plazzi, G d’Ettore, M Fusto, I Coledan, A De Vito, M Fabbiani, F Montagnani, A Franco, R Fontana Del Vecchio, D Francisci, C Di Giuli, GC Orofino, G Calleri, G Accardo, C Tascini, A Londero, G Battagin, S Nicolè, G Starnini, S Dell’Isola International Journal of Infectious Diseases, 2026 BACKGROUND: The COVID-19 pandemic profoundly disrupted healthcare services. This study assessed the impact of the pandemic on the incidence, characteristics, and outcomes of late HIV diagnosis (LD) in Italy. METHODS: All people with HIV (PWH) enrolled in Italian Cohort Naïve Antiretrovirals during 2016-2019 (prepandemic) and 2021-2024 (postpandemic), and diagnosed with HIV within 3 months before enrolment, were included. LD was defined as CD4 < 350 cells/mm³ or an AIDS-defining event (ADE) within 3 months of HIV diagnosis; AIDS presentation (AIDS-P) was considered an ADE at diagnosis. Annual incidence, socio-demographic determinants, and survival outcomes were compared between periods using Poisson regression, Cox proportional hazards models, and Fine-Gray competing risk models. RESULTS: Among 5724 newly diagnosed PWH, 56% were enrolled in prepandemic and 44% postpandemic. Overall, 58% presented late and 13% as AIDS-P, with proportions stable across periods. Risk factors for LD-female sex, older age, foreign nationality, heterosexual transmission, lower education, and unemployment-remained consistent, with no significant interaction by time (P = 0.39). During follow-up, 151 deaths occurred. LD and especially AIDS-P were associated with substantially increased all-cause mortality compared with non-LD, particularly within the first-year postdiagnosis. Adjusted hazard ratios were 2.96 for LD and 6.51 for AIDS-P prepandemic, and 8.64 and 17.99 postpandemic. No excess risk was observed for non-AIDS-related mortality. CONCLUSION: The prevalence and determinants of LD and AIDS-P in Italy remained stable before and after the COVID-19 pandemic. However, late presentation continues to carry a heavy mortality burden, underscoring the urgent need to strengthen early testing and prompt linkage to care.
HIV infection among adolescents and young adults in Italy: Epidemiology, viro-immunological and treatment outcomes Francesco Maria Fusco, Ilaria Mastrorosa, Francesca Vichi, Adriana Cervo, Annalisa Saracino, Leonardo Calza, Eugenia Quiros-Roldan, Maria Elisabetta Teti, Andrea Costantini, Antonella Cingolani, Enrico Girardi, Andrea Antinori, Antonella d’Arminio Monforte, Alessandro Tavelli International Journal of Infectious Diseases, 2026 OBJECTIVES: No previous study described adolescents and young adults (AYAs) with HIV in Italy. Aims were to investigate the temporal trend of AYAs enrolment in the ICONA cohort over 2014-2023, and to compare their baseline characteristics and antiretroviral therapy (ART) outcomes with adults. METHODS: All subjects enrolled in ICONA, the Italian cohort enrolling HIV-1 positive individuals from ART-naïve, over 2014-2023 were grouped into: AYAs (18-24 years old) and adults (≥25). Study outcomes were: time to first ART start, time to treatment discontinuation (TD) of first-line regimen, cause-specific TD, virologic failure, and loss-to-follow-up (LTFU). RESULTS: Overall, 9519 participants: 653 AYAs (6.9%) and 8,866 adults (93.1%). Excluding the decline recorded in 2020, the percentage of AYAs enrolled showed a similar trend before- and after-COVID. Compared with adults, AYAs had a milder clinical presentation, a better viro-immunological status, a higher mean change of cluster of differentiation 4 count over 24 months and, after adjusting, a higher risk of TD for patient's choice/adherence-related issues and LTFU. CONCLUSIONS: The less advanced clinical presentation and more robust immune recovery of AYAs, might depend upon more recent HIV infection, better thymic function, and lower immune activation. The higher risk of TD due to patient's choice/adherence-related issues and LTFU among AYAs is a major concern and suggests the need to create ad hoc clinical care pathways.
Prevalence of Circulating Autoantibodies Against G-Protein-Coupled Receptors as Potential Biomarkers for Long COVID: Preliminary Investigations Marta Camici, Marta Franco, Lorenzo Talamanca, Jessica Paulicelli, Liliana Scarnecchia, Manuela Petino, Valentina Mazzotta, Ilaria Mastrorosa, Eleonora Cimini, Eleonora Tartaglia, Stefania Notari, Paolo Zuppi, Roberto Baldelli, Maria Grazia Bocci, Fabrizio Maggi, Enrico Girardi, Andrea Antinori International Journal of Molecular Sciences, 2026 This prospective, single-center, case-control study investigated circulating autoantibodies (AAbs) targeting G protein-coupled receptors (GPCRs) in Long COVID (LC) patients to identify potential diagnostic biomarkers and therapeutic targets. Fifteen participants were enrolled at the LC clinic in Rome: eleven with severe LC—defined as >4 persistent symptoms (fatigue, cognitive impairment, poor exercise tolerance, dyspnea, arthralgia, or dysautonomic manifestations) >3 months post-infection—and four asymptomatic post-COVID (APC) individuals. Fatigue was assessed using the Fatigue Assessment Scale (FAS ≥ 22; severe ≥ 35). Auto-Abs against AT1R, endothelin receptor A, adrenergic (α1, α2, β1, β2), and muscarinic (M1–M5) receptors were quantified, along with blood cortisol and ACTH levels. SARS-CoV-2-specific T-cell responses to Spike and Nucleocapsid proteins were evaluated by ELISpot assay. In our small cohort, LC patients were younger, had fewer comorbidities (p = 0.03), fewer vaccine doses (p = 0.03), and higher FAS scores (33 vs. 12; p = 0.001). Mean GPCR AAbs levels were higher in LC than in APC (8.88 vs. 5.45 Units/mL; p = 0.17), indicating a coherent autoimmune signature in LC that correlates with symptom development. Morning cortisol was lower in LC (12.7 vs. 17 mg/dL; p = 0.01), and T-cell responses tended to be weaker. These findings suggest GPCR AAbs may serve as biomarkers and therapeutic targets for a subset of patients, guiding diagnosis and treatments with IV immunoglobulin or immunoadsorption.
Intravenous immunoglobulin treatment for long COVID: a case report of clinical and immunological findings Marta Camici, Eva Piano Mortari, Giulia Del Duca, Eleonora Cimini, Valentina Mazzotta, Chiara De Ponte, Ilaria Mastrorosa, Stefania Mazzotta, Carmela Pinnetti, Stefania Notari, Veronica Bordoni, Simona Gili, Giusi Prencipe, Fabrizio Maggi, Rita Carsetti, Enrico Girardi, Andrea Antinori, Chiara Agrati Lancet Infectious Diseases, 2026
Salivary cortisol in long COVID: a marker of broader stress system and circadian rhythm dysregulation Marta Camici, Marta Franco, Lorenzo Talamanca, Manuela Petino, Jessica Paulicelli, Liliana Scarnecchia, Lucia Ciavarella, Tiziana Orzilli, Francesca Balducelli, Valentina Mazzotta, Ilaria Mastrorosa, Eleonora Cimini, Eleonora Tartaglia, Stefania Notari, Fabrizio Maggi, Enrico Girardi, Roberto Baldelli, Paolo Zuppi, Andrea Antinori Frontiers in Cellular and Infection Microbiology, 2026 Introduction Long COVID (LC) has been associated with hypothalamic–pituitary–adrenal (HPA) axis dysfunction, although findings from blood cortisol measurements remain inconsistent. We hypothesized that LC patients exhibit a disrupted diurnal cortisol rhythm and that salivary cortisol (SC) profiling may provide a more accurate assessment of HPA activity. Methods This prospective, single-center, case–control study was conducted at a Long COVID clinic in Rome between February 2023 and March 2024 and included 96 participants evaluated at least 28 days after confirmed SARS-CoV-2 infection. LC was defined as one or more new or persistent symptoms and classified as severe when four or more of the following were present: fatigue, cognitive impairment, exercise intolerance, dyspnea, arthralgia, or dysautonomia. SC was measured at 8:00 AM, 3:00 PM, and 11:00 PM. Results The cohort (mean age 58.1 ± 14.8 years; 60% female; all White) included 83 LC patients (80% moderate, 20% severe) and 13 asymptomatic post-COVID (APC) individuals. Compared with healthy controls, both LC and APC groups showed reduced morning SC (p&lt;0.01), flattened diurnal variation, and elevated evening SC, indicating loss of the normal morning peak and nocturnal decline. Blood cortisol levels did not differ among groups, but LC patients had higher ACTH than APC (26 pg/mL vs 13 pg/mL; p&lt;0.01), suggesting compensatory HPA activation. One LC patient (1.2%) was diagnosed with adrenal insufficiency. Discussion These exploratory findings suggest a disrupted circadian cortisol rhythm in individuals after COVID-19, with altered HPA axis dynamics that may be associated with disease severity.
First autochthonous mpox virus clade Ib outbreak in Italy linked to sexual transmission Valentina Mazzotta, Andrea Bongiovanni, Licia Bordi, Marco Ridolfi, Gabriella De Carli, Rebecca Jo Steiner, Francesca Colavita, Gabriella d’Ettorre, Rozenn Esvan, Cesare Ernesto Maria Gruber, Giorgio Nicolo’ Malatesta, Luigi Coppola, Sara Covino, Maria Beatrice Valli, Ilaria Mastrorosa, Maria Concetta Fusco, Fabrizio Carletti, Katia Casinelli, Loredana Sarmati, Enrico Girardi, Andrea Siddu, Claudio Maria Mastroianni, Fabrizio Maggi, Andrea Antinori, Francesco Vairo Clinical Microbiology and Infection, 2026
Implementing the National Vaccination Plan in people with HIV in Italy: A survey among ICONA centres Antonio Russo, Andrea Giacomelli, Andrea De Vito, Maria Mazzitelli, Manuela Ceccarelli, Sara De Benedittis, Alessandro Tavelli, Massimo Cernuschi, Lucia Taramasso, Miriam Lichtner, Valentina Mazzotta, Enrico Girardi, Cristina Mussini, Sergio Lo Caputo, Antonella d'Arminio Monforte, and HIV Medicine, 2026 The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500 000 copies/mL in 2018–2023 in Italy: data from the ICONA Foundation Cohort Study Antonella d'Arminio Monforte, Nicolò Lentini, Alessandro Tavelli, Stefano Rusconi, Federica Sozio, Alessandra Guida, Emanuela Zappulo, Gabriele Loi, Annalisa Mondi, Roberta Gagliardini, Giulia Marchetti, Francesca Ceccherini-Silbrstein, Valentina Mazzotta, Enrico Girardi, Roberta Pastorino, Andrea Giacomelli, Carlo F. Perno, Board of directors, A d'Arminio Monforte, A. Antinori, S. Antinori, A. Castagna, M. Cernuschi, L. Cosmaro, A. Di Biagio, E. Dibrino, E. Girardi, S. Lo Caputo, G.C. Marchetti, C. Mussini, E. Quiros-Roldan, L. Sarmati, B. Suligoi, C. Torti, Scientific secretariat, A d’Arminio Monforte, A. Antinori, A. Castagna, F. Ceccherini-Silberstein, A. Cingolani, A. Cozzi-Lepri, A. Di Biagio, R. Gagliardini, A. Giacomelli, E. Girardi, A. Gori, S. Lo Caputo, G. Marchetti, F. Maggiolo, C. Mussini, M. Puoti, C.F. Perno, A. Tavelli, Steering committee, A Antinori, A. Bandera, S. Bonora, A. Calcagno, A. Castagna, F. Ceccherini-Silberstein, A. Cervo, A. Cingolani, P. Cinque, A. Cozzi-Lepri, A.d’Arminio Monforte, A. De Vito, A. Di Biagio, A. Fortunato, R. Gagliardini, A.M. Geretti, A. Giacomelli, E. Girardi, N. Gianotti, A. Gori, G. Guaraldi, S. Lanini, G. Lapadula, M. Lichtner, A. Lai, S. Lo Caputo, G. Madeddu, F. Maggiolo, V. Malagnino, I. Mastrorosa, G. Marchetti, A. Mondi, V. Mazzotta, C. Muccini, C. Mussini, S. Nozza, C.F. Perno, S. Piconi, C. Pinnetti, M.C. Poliseno, M. Puoti, E Quiros Roldan, R. Rossotti, S. Rusconi, M.M. Santoro, A. Saracino, L. Sarmati, V. Spagnuolo, N. Squillace, V. Svicher, L. Taramasso, C. Tincati, C. Torti, A. Vergori, Statistical, monitoring team, A. Cozzi-Lepri, S. De Benedittis, I. Fanti, M. Giotta, S. Lanini, N. Lentini, M. Muccio, R. Pastorino, A. Rodano’, A. Roen, A. Tavelli, Community advisory board, S. Bazzichetto, M. Cernuschi, L. Cosmaro, A. Perziano, V. Calvino, D. Russo, M. Farinella, N. Policek, V.L. Del Negro, Biological Bank INMI, San Paolo, S. Carrara, S. Graziano, G. Prota, H. Sadeghi, V. Sala, S. Truffa, D. Vincenti, R. Rovito, Participating physicians, centers, Italy A. Giacometti, A. Costantini, V. Barocci, A. Saracino, C. Santoro, E. Milano, L. Comi, C. Suardi, P. Viale, L. Badia, S. Cretella, E.M. Erne, A. Pieri, E Quiros Roldan, E. Focà, S. Minniti, B. Menzaghi, C. Abeli, L. Chessa, F. Pes, P. Maggi, L. Alessio, G. Nunnari, B.M. Celesia, J. Vecchiet, K. Falasca, A. Pan, S Dal Zoppo, D. Segala, A. Bartoloni, B. Borchi, C. Costa, A. Castellaccio, S. Lo Caputo, A. Narducci, M. Bassetti, E. Pontali, S. Blanchi, N. Bobbio, C. Del Borgo, R. Marocco, G. Mancarella, S. Piconi, C. Molteni, S. Rusconi, G. Canavesi, P. Colletti, G. Pellicanò, Y. Russotto, G. Marchetti, S. Antinori, A. Gori, M. Puoti, A. Castagna, A. Bandera, V. Bono, G. Bozzi, M.V. Cossu, V. Iannone, R. Lolatto, M.C. Moioli, G. Carrozzo, N. Capra, M. Augello, D. Moschese, C. Mussini, M. Menozzi, P. Bonfanti, G. Lapadula, V. Sangiovanni, I. Gentile, V. Esposito, N. Coppola, F.M. Fusco, G. Di Filippo, V. Rizzo, N. Sangiovanni, S. Martini, A.M. Cattelan, D. Leoni, A. Cascio, C. Iaria, M. Trizzino, R. Gulminetti, D. Francisci, E. Schiaroli, G. Parruti, F. Sozio, D. Messeri, S.I. Bonelli, C. Lazzaretti, R. Corsini, A. Antinori, C. Torti, G. D'Ettorre, L. Sarmati, A. Latini, A. Cingolani, G. Micheli, S. Lamonica, M. Capozzi, M. Camici, I. Mezzaroma, M Rivano Capparuccia, G. Iaiani, C. Stingone, L. Gianserra, J. Paulicelli, M.M. Plazzi, L. Bortolani, M. Fusto, I. Coledan, G. Madeddu, G. Moi, M. Fabbiani, F. Montagnani, A. Franco, R Fontana Del Vecchio, D. Francisci, C. Di Giuli, G.C. Orofino, G. Calleri, G. Di Perri, S. Bonora, D. Meloni, C. Tascini, A. Londero, G. Battagin, S. Nicolè, G. Starnini, S. Dell’Isola Clinical Microbiology and Infection, 2026
CT changes in a randomized trial comparing early therapies in an outpatient population at high risk of severe COVID19 disease Ilaria Mastrorosa, Alessandro Cozzi-Lepri, Giulia Matusali, Francesca Colavita, Simone Lanini, Martina Rueca, Alessandra Oliva, Giulia Berno, Alessandra Vergori, Silvia Rosati, Jessica Paulicelli, Enrico Girardi, Emanuele Nicastri, Fabrizio Maggi, Andrea Antinori, Valentina Mazzotta, , Samir Al Moghazi, Massimo Andreoni, Nazario Bevilacqua, Elisa Biliotti, Pierluigi Blanc, Raffaele Bruno, Emanuela Caraffa, Antonio Cascio, Anna Maria Cattelan, Roberto Cauda, Fabrizio Carletti, Carlotta Cerva, Angela Corpolongo, Alessandra D’Abramo, Federico De Zottis, Silvia Di Bari, Giovanni Di Perri, Massimo Di Pietro, Davide Roberto Donno, Francesca Faraglia, Francesca Gavaruzzi, Ivan Gentile, Maria Letizia Giancola, Emanuela Giombini, Andrea Gori, Paolo Grossi, Cesare Ernesto Maria Gruber, Carmelo Iacobello, Chiara Iaria, Marco Libanore, Raffaella Libertone, Miriam Lichtner, Laura Loiacono, Andrea Mariano, Marco Massari, Claudio Maria Mastroianni, Silvia Meschi, Eugenia Milozzi, Cristina Mussini, Roberto Parrella, Massimo Puoti, Giuliano Rizzardini, Annalisa Saracino, Laura Scorzolini, Eliana Specchiarello, Marcello Tavio, Carlo Torti, Pierluigi Viale, Serena Vita, Pietro Vittozzi Scientific Reports, 2025
Inflammatory Milieu and Specific T-Cell Response Observed Three Months and One Year After SARS-CoV-2 Infection in Long COVID Subjects Eleonora Cimini, Alessandra Vergori, Claudia Cimaglia, Eleonora Tartaglia, Stefania Notari, Francesca Colavita, Giulia Matusali, Ilaria Mastrorosa, Valentina Mazzotta, Pierangelo Chinello, Paola Mencarini, Maria Letizia Giancola, Amina Abdeddaim, Rita Casetti, Germana Grassi, Simona Gili, Flavia Cristofanelli, Fabrizio Maggi, Pierluca Piselli, Enrico Girardi, Andrea Antinori, Marta Camici International Journal of Molecular Sciences, 2025
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: Real-life data from the ICONA Foundation cohort Alessandra Vergori, Alessandro Cozzi-Lepri, Sergio Lo Caputo, Alessandro Tavelli, Valentina Mazzotta, Elisabetta Schiaroli, Giancarlo Orofino, Cristina Mussini, Silvia Nozza, Antonella Cingolani, Andrea Antinori, Antonella d’Arminio Monforte, , A d’Arminio Monforte, A Antinori, S Antinori, A Castagna, R Cauda, G Di Perri, E Girardi, R Iardino, A Lazzarin, G C Marchetti, C Mussini, E Quiros-Roldan, L Sarmati, B Suligoi, F von Schloesser, P Viale, A d’Arminio Monforte, A Antinori, A Castagna, F Ceccherini-Silberstein, A Cingolani, A Cozzi-Lepri, A Di Biagio, E Girardi, A Gori, S Lo Caputo, G Marchetti, F Maggiolo, C Mussini, M Puoti, C F Perno, C Torti, A Antinori, A Bandera, S Bonora, A Calcagno, D Canetti, A Castagna, F Ceccherini-Silberstein, A Cervo, A Cingolani, P Cinque, A Cozzi-Lepri, A d’Arminio Monforte, A Di Biagio, R Gagliardini, A Giacomelli, E Girardi, N Gianotti, A Gori, G Guaraldi, S Lanini, G Lapadula, M Lichtner, A Lai, S Lo Caputo, G Madeddu, F Maggiolo, V Malagnino, G Marchetti, A Mondi, V Mazzotta, C Mussini, S Nozza, C F Perno, S Piconi, C Pinnetti, M Puoti, E Quiros Roldan, R Rossotti, S Rusconi, M M Santoro, A Saracino, L Sarmati, V Spagnuolo, N Squillace, V Svicher, L Taramasso, C Torti, A Vergori, A Cozzi-Lepri, S De Benedittis, I Fanti, N Lentini, M Giotta, R Pastorino, A Rodanò, A Roen, A Tavelli, S Bazzichetto, M Cernuschi, L Cosmaro, A Perziano, V Calvino, D Russo, M Farinella, N Policek, V L Del Negro, M Augello, S Carrara, S Graziano, G Prota, S Truffa, D Vincenti, R Rovito, A Giacometti, A Costantini, V Barocci, A Saracino, C Santoro, E Milano, L Comi, C Suardi, P Viale, L Badia, S Cretella, E M Erne, A Pieri, E Quiros Roldan, E Focà, B Menzaghi, C Abeli, L Chessa, F Pes, P Maggi, L Alessio, G Nunnari, B M Celesia, J Vecchiet, K Falasca, A Pan, S Dal Zoppo, D Segala, F Bartalesi, A Bartoloni, B Borchi, C Costa, S Lo Caputo, A Narducci, M Bassetti, E Pontali, S Blanchi, N Bobbio, C Del Borgo, R Marocco, G Mancarella, S Piconi, C Molteni, S Rusconi, G Canavesi, G Pellicanò, Y Russotto, G Marchetti, S Antinori, A Gori, M Puoti, A Castagna, A Bandera, V Bono, M V Cossu, A Giacomelli, R Lolatto, M C Moioli, L Pezzati, S Diotallevi, C Tincati, C Mussini, M Menozzi, P Bonfanti, G Lapadula, V Sangiovanni, I Gentile, V Esposito, N Coppola, F M Fusco, G Di Filippo, V Rizzo, N Sangiovanni, S Martini, A M Cattelan, D Leoni, A Cascio, M Trizzino, D Francisci, E Schiaroli, G Parruti, F Sozio, D Messeri, S I Bonelli, C Lazzaretti, R Corsini, A Antinori, R Cauda, C Mastroianni, L Sarmati, A Latini, A Cingolani, I Mastrorosa, S Lamonica, M Capozzi, M Camici, I Mezzaroma, M Rivano Capparuccia, G Iaiani, C Stingone, L Gianserra, J Paulicelli, M M Plazzi, G d’Ettore, M Fusto, I Coledan, G Madeddu, A De Vito, M Fabbiani, F Montagnani, A Franco, R Fontana Del Vecchio, D Francisci, C Di Giuli, G C Orofino, G Calleri, G Di Perri, S Bonora, G Accardo, C Tascini, A Londero, G Battagin, S Nicolè, G Starnini, S Dell’Isola Journal of Antimicrobial Chemotherapy, 2025
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data Pierluca Piselli, Alessandro Tavelli, Claudia Cimaglia, Camilla Muccini, Alessandra Bandera, Giulia C. Marchetti, Carlo Torti, Valentina Mazzotta, Luca Pipitò, Alessandro Caioli, Enrico Girardi, Andrea Antinori, Diego Serraino, Antonella d'Arminio Monforte, Antonella Cingolani, and International Journal of Cancer, 2025
Comparative Analysis of Early COVID-19 Treatment Efficacy in a Multicentric Regional Cohort in Italy: Emulation of a Series of Target Trials Valentina Mazzotta, Alessandro Cozzi Lepri, Cosmo Del Borgo, Simone Lanini, Silvia Meschi, Silvia Garattini, Silvia Rosati, Valentina Siciliano, Alessandra Vergori, Luigi Coppola, Antonio Falletta, Anna Carraro, Giulia Gramigna, Alessandra Oliva, Elena Matteini, Andrea Gasperin, Giuseppina Giannico, Ilaria Mastrorosa, Giulia Matusali, Alessandra D'Abramo, Raffaella Marocco, Eugenia Milozzi, Carlotta Cerva, Francesca Gavaruzzi, Martina Rueca, Claudia Cimaglia, Pierluca Piselli, Massimo Fantoni, Enrico Girardi, Loredana Sarmati, Claudio M. Mastroianni, Massimo Andreoni, Carlo Torti, Emanuele Nicastri, Fabrizio Maggi, Miriam Lichtner, Andrea Antinori, and Journal of Medical Virology, 2025
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view A Cingolani, A Tavelli, S De Benedittis, I Mastrorosa, C Muccini, T Bini, A Carraro, M Compagno, M Mazzitelli, M Guastavigna, M Cernuschi, C Torti, A Antinori, A d’Arminio Monforte, , A d’Arminio Monforte, A Antinori, S Antinori, A Castagna, R Cauda, G Di Perri, E Girardi, R Iardino, A Lazzarin, G C Marchetti, C Mussini, E Quiros-Roldan, L Sarmati, B Suligoi, F von Schloesser, P Viale, A d’Arminio Monforte, A Antinori, A Castagna, F Ceccherini-Silberstein, A Cingolani, A Cozzi-Lepri, A Di Biagio, E Girardi, A Gori, S Lo Caputo, G Marchetti, F Maggiolo, C Mussini, M Puoti, C F Perno, C Torti, A Antinori, F Bai, A Bandera, S Bonora, A Calcagno, D Canetti, A Castagna, F Ceccherini-Silberstein, A Cervo, A Cingolani, P Cinque, A Cozzi-Lepri, A d’Arminio Monforte, A Di Biagio, R Gagliardini, A Giacomelli, E Girardi, N Gianotti, A Gori, G Guaraldi, S Lanini, G Lapadula, M Lichtner, A Lai, S Lo Caputo, G Madeddu, F Maggiolo, V Malagnino, G Marchetti, A Mondi, V Mazzotta, C Mussini, S Nozza, C F Perno, S Piconi, C Pinnetti, M Puoti, E Quiros Roldan, R Rossotti, S Rusconi, M M Santoro, A Saracino, L Sarmati, V Spagnuolo, N Squillace, V Svicher, L Taramasso, C Torti, A Vergori, A Cozzi-Lepri, S De Benedittis, I Fanti, M Giotta, C Marelli, A Rodano’, A Tavelli, M Cernuschi, L Cosmaro, A Perziano, V Calvino, D Russo, M Farinella, N Policek, V L Del Negro, M Augello, S Carrara, S Graziano, G Prota, S Truffa, D Vincenti, R Rovito, A Giacometti, A Costantini, V Barocci, A Saracino, C Santoro, E Milano, L Comi, C Suardi, P Viale, L Badia, S Cretella, E M Erne, A Pieri, E Quiros Roldan, E Focà, C Minardi, B Menzaghi, C Abeli, L Chessa, F Pes, P Maggi, L Alessio, G Nunnari, B M Celesia, J Vecchiet, K Falasca, A Pan, S Dal Zoppo, D Segala, M A Di Pietro, C Costa, S Lo Caputo, S Ferrara, M Bassetti, E Pontali, S Blanchi, N Bobbio, G Mazzarello, M Lichtner, L Fondaco, S Piconi, C Molteni, S Rusconi, G Canavesi, G Pellicanò, G Marchetti, S Antinori, G Rizzardini, M Puoti, A Castagna, A Bandera, V Bono, M V Cossu, A Giacomelli, R Lolatto, M C Moioli, L Pezzati, S Diotallevi, C Tincati, C Mussini, M Menozzi, P Bonfanti, G Lapadula, V Sangiovanni, I Gentile, V Esposito, N Coppola, F M Fusco, G Di Filippo, V Rizzo, N Sangiovanni, S Martini, A M Cattelan, D Leoni, A Cascio, M Trizzino, D Francisci, E Schiaroli, G Parruti, F Sozio, D Messeri, S I Bonelli, C Lazzaretti, R Corsini, A Antinori, R Cauda, C Mastroianni, L Sarmati, A Latini, A Cingolani, I Mastrorosa, S Lamonica, M Capozzi, M Camici, M Rivano Capparuccia, G Iaiani, C Stingone, L Gianserra, J Paulicelli, M M Plazzi, G d’Ettore, M Fusto, I Coledan, G Madeddu, A De Vito, M Fabbiani, F Montagnani, A Franco, R Fontana Del Vecchio, B M Pasticci, C Di Giuli, G C Orofino, G Calleri, G Di Perri, S Bonora, G Accardo, C Tascini, A Londero, G Battagin, S Nicolè, G Starnini, S Dell’Isola Journal of Antimicrobial Chemotherapy, 2024
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21 Lavinia Fabeni, Daniele Armenia, Isabella Abbate, Roberta Gagliardini, Valentina Mazzotta, Ada Bertoli, William Gennari, Federica Forbici, Giulia Berno, Lorenzo Piermatteo, Vanni Borghi, Carmela Pinnetti, Alessandra Vergori, Annalisa Mondi, Giustino Parruti, Fiorella Di Sora, Marco Iannetta, Miriam Lichtner, Alessandra Latini, Cristina Mussini, Loredana Sarmati, Carlo Federico Perno, Enrico Girardi, Andrea Antinori, Francesca Ceccherini-Silberstein, Fabrizio Maggi, Maria Mercedes Santoro, , F Ceccherini-Silberstein, M C Bellocchi, L Carioti, M M Santoro, M Andreoni, M Iannetta, A Bertoli, L Sarmati, V Malagnino, E Teti, D Armenia, A Antinori, F Baldini, R Bellagamba, G Berno, M Camici, S Cicalini, F De Zottis, R Esvan, L Fabeni, F Forbici, M Fusto, R Gagliardini, S Gebremeskel, F Gili, E Girardi, E Grilli, S Grisetti, I Mastrorosa, V Mazzotta, A Mondi, N Orchi, S Ottou, C Pinnetti, S Pittalis, D Pizzi, M Plazzi, A Vergori, A R Buonomini, M Giuliani, A Latini, A Pacifici, C F Perno, V Belvisi, C Del Borgo, A Carraro, M Lichtner, R Marocco, V Borghi, C Mussini, W Gennari Journal of Antimicrobial Chemotherapy, 2024
SARS-CoV-2 mRNA vaccination and short-term changes in viral load and CD4/CD8 T-cell counts in people living with HIV Alessandra Vergori, Alessandro Cozzi-Lepri, Alessandro Tavelli, Valentina Mazzotta, Anna Maria Azzini, Roberta Gagliardini, Ilaria Mastrorosa, Alessandra Latini, Giovanni Pellicanò, Lucia Taramasso, Francesca Ceccherini-Silberstein, Maddalena Giannella, Evelina Tacconelli, Giulia Marchetti, Antonella d'Arminio Monforte, Andrea Antinori International Journal of Infectious Diseases, 2024
Molnupiravir increases SARS-CoV-2 genome diversity and complexity: A case-control cohort study Cesare Ernesto Maria Gruber, Fabio Giovanni Tucci, Emanuela Giombini, Valentina Mazzotta, Pietro Giorgio Spezia, Martina Rueca, Ilaria Mastrorosa, Lavinia Fabeni, Giulia Berno, Ornella Butera, Silvia Rosati, Eliana Specchiarello, Fabrizio Carletti, Daniele Focosi, Emanuele Nicastri, Enrico Girardi, Andrea Antinori, Fabrizio Maggi Journal of Medical Virology, 2024
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study Valentina Mazzotta, Alessandro Cozzi Lepri, Giulia Matusali, Eleonora Cimini, Pierluca Piselli, Camilla Aguglia, Simone Lanini, Francesca Colavita, Stefania Notari, Alessandra Oliva, Silvia Meschi, Rita Casetti, Vanessa Mondillo, Alessandra Vergori, Aurora Bettini, Germana Grassi, Carmela Pinnetti, Daniele Lapa, Eleonora Tartaglia, Paola Gallì, Annalisa Mondi, Giulia Montagnari, Roberta Gagliardini, Emanuele Nicastri, Miriam Lichtner, Loredana Sarmati, Enrica Tamburrini, Claudio Mastroianni, Christof Stingone, Andrea Siddu, Alessandra Barca, Carla Fontana, Chiara Agrati, Enrico Girardi, Francesco Vaia, Fabrizio Maggi, Andrea Antinori, Enza Anzalone, Marta Camici, Fabio Cannone, Priscilla Caputi, Claudia Cimaglia, Rita Corso, Flavia Cristofanelli, Stefania Cruciani, Nicola De Marco, Chiara De Ponte, Giulia Del Duca, Paolo Faccendini, Francesca Faraglia, Augusto Faticoni, Marisa Fusto, Saba Gebremeskel, Maria Letizia Giancola, Giuseppina Giannico, Simona Gili, Maria Rosaria Iannella, Angela Junea, Alessandra Lamonaca, Alessandra Marani, Erminia Masone, Ilaria Mastrorosa, Stefania Mazzotta, Alessandra Nappo, Giorgia Natalini, Alfredo Parisi, Sara Passacantilli, Jessica Paulicelli, Maria Maddalena Plazzi, Adriano Possi, Gianni Preziosi, Silvia Rosati, Marika Rubino, Pietro Scanzano, Laura Scorzolini, Virginia Tomassi, Maurizio Vescovo, Serena Vita, Luciano Caterini, Luigi Coppola, Dimitra Kontogiannis, Gabriella D'Ettorre, Marco Ridolfi, Simona Di Giambenedetto, Damiano Farinacci, Alessandra Latini, Mauro Marchili, Raffaella Marocco Eclinicalmedicine, 2024
Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study) Marta Camici, Roberta Gagliardini, Simone Lanini, Giulia Del Duca, Annalisa Mondi, Sandrine Ottou, Maria M. Plazzi, Federico De Zottis, Carmela Pinnetti, Alessandra Vergori, Elisabetta Grilli, Ilaria Mastrorosa, Valentina Mazzotta, Jessica Paulicelli, Rita Bellagamba, Eleonora Cimini, Eleonora Tartaglia, Stefania Notari, Massimo Tempestilli, Stefania Cicalini, Alessandra Amendola, Isabella Abbate, Federica Forbici, Lavinia Fabeni, Enrico Girardi, Francesco Vaia, Fabrizio Maggi, Andrea Antinori International Journal of Antimicrobial Agents, 2024
Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis Giulia Del Duca, Alessandro Tavelli, Ilaria Mastrorosa, Camilla Aguglia, Simone Lanini, Anna Brita, Roberta Gagliardini, Serena Vita, Alessandra Vergori, Jessica Paulicelli, Giorgia Natalini, Angela D’Urso, Pierluca Piselli, Paola Gallì, Vanessa Mondillo, Claudio Mastroianni, Enrica Tamburrini, Loredana Sarmati, Christof Stingone, Miriam Lichtner, Emanuele Nicastri, Massimo Farinella, Filippo Leserri, Andrea Siddu, Fabrizio Maggi, Antonella d’Arminio Monforte, Francesco Vairo, Alessandra Barca, Francesco Vaia, Enrico Girardi, Valentina Mazzotta, Andrea Antinori Vaccines, 2023
Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes Annalisa Mondi, Ilaria Mastrorosa, Pierluca Piselli, Claudia Cimaglia, Giulia Matusali, Fabrizio Carletti, Giuseppina Giannico, Eugenia Milozzi, Elisa Biliotti, Silvia Di Bari, Pierangelo Chinello, Alessia Beccacece, Francesca Faraglia, Pietro Vittozzi, Silvia Mosti, Nardi Tetaj, Giulia Valeria Stazi, Carmela Pinnetti, Marta Camici, Alberto D'Annunzio, Alessandra Marani, Lavinia Fabeni, Eliana Specchiarello, Cesare Ernesto Maria Gruber, Alberta Villanacci, Sabrina Minicucci, Anna Rosa Garbuglia, Stefania Ianniello, Luisa Marchioni, Fabrizio Taglietti, Gianpiero D'Offizi, Fabrizio Palmieri, Emanuele Nicastri, Fabrizio Maggi, Francesco Vaia, Enrico Girardi, Andrea Antinori Journal of Medical Virology, 2023
Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study) Ilaria Mastrorosa, Roberta Gagliardini, Francesco Vladimiro Segala, Annalisa Mondi, Patrizia Lorenzini, Carlotta Cerva, Eleonora Taddei, Francesca Bai, Alessandra Vergori, Marcantonio Negri, Carmela Pinnetti, Stefania Cicalini, Rita Murri, Valentina Mazzotta, Marta Camici, Silvia Mosti, Teresa Bini, Gaetano Maffongelli, Alessia Beccacece, Eugenia Milozzi, Marco Iannetta, Silvia Lamonica, Marisa Fusto, Maria Maddalena Plazzi, Sandrine Ottou, Miriam Lichtner, Massimo Fantoni, Massimo Andreoni, Loredana Sarmati, Roberto Cauda, Enrico Girardi, Emanuele Nicastri, Antonella D'Arminio Monforte, Fabrizio Palmieri, Antonella Cingolani, Francesco Vaia, Andrea Antinori, Chiara Agrati, Massimo Andreoni, Andrea Antinori, Francesca Bai, Alessia Beccacece, Filippo Barreca, Maria Paola Bertuccio, Teresa Bini, Evangelo Boumis, Marta Camici, Roberto Cauda, Carlotta Cerva, Stefania Cicalini, Antonella Cingolani, Antonella D'Arminio Monforte, Angela D'Urso, Margherita De Masi, Federico De Zottis, Cosmo Del Borgo, Francesco Di Gennaro, Arianna Emiliozzi, Massimo Fantoni, Laura Fondaco, Marisa Fusto, Roberta Gagliardini, Francesca Giovannenze, Elisabetta Grilli, Marco Iannetta, Daniele Iodice, Miriam Lichtner, Patrizia Lorenzini, Gaetano Maffongelli, Erminia Masone, Barbara Massa, Ilaria Mastrorosa, Valentina Mazzotta, Paola Mencarini, Eugenia Milozzi, Annalisa Mondi, Silvia Mosti, Rita Murri, Marcantonio Negri, Emanuele Nicastri, Gian Piero Oliva, Giovanna Onnelli, Sandrine Ottou, Pier Giorgio Pace, Fabrizio Palmieri, Jessica Paulicelli, Carmela Pinnetti, Maria Maddalena Plazzi, Loredana Sarmati, Francesco Vladimiro Segala, Chiara Sorace, Eleonora Taddei, Alessandra Vergori, Pietro Vitale Eclinicalmedicine, 2023
Unawareness of HCV serostatus among persons newly diagnosed with HIV Paola Scognamiglio, Assunta Navarra, Nicoletta Orchi, Gabriella De Carli, Silvia Pittalis, Ilaria Mastrorosa, Ubaldo Visco Comandini, Chiara Agrati, Andrea Antinori, Vincenzo Puro, Giuseppe Ippolito, Enrico Girardi Journal of Infection and Public Health, 2019
Genetic divergence of HIV-1 B subtype in Italy over the years 2003–2016 and impact on CTL escape prevalence Claudia Alteri, Lavinia Fabeni, Rossana Scutari, Giulia Berno, Domenico Di Carlo, Caterina Gori, Ada Bertoli, Alessandra Vergori, Ilaria Mastrorosa, Rita Bellagamba, Cristina Mussini, Manuela Colafigli, Francesco Montella, Alfredo Pennica, Claudio Maria Mastroianni, Enrico Girardi, Massimo Andreoni, Andrea Antinori, Valentina Svicher, Francesca Ceccherini-Silberstein, Carlo Federico Perno, Maria Mercedes Santoro Scientific Reports, 2018
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART Francesca Ceccherini-Silberstein, Alessandro Cozzi Lepri, Claudia Alteri, Esther Merlini, Matteo Surdo, Giulia Marchetti, Maria Rosaria Capobianchi, Andrea De Luca, Nicola Gianotti, Pierluigi Viale, Massimo Andreoni, Andrea Antinori, Carlo Federico Perno, Antonella d’Arminio Monforte, ICONA Foundation Study Group, A d’Arminio Monforte, A Antinori, A Castagna, F Castelli, R Cauda, G Di Perri, M Galli, R Iardino, G Ippolito, A Lazzarin, G C Marchetti, C F Perno, G Rezza, F von Schloesser, P Viale, A d’Arminio Monforte, A Antinori, A Castagna, F Ceccherini-Silberstein, A Cozzi-Lepri, E Girardi, S Lo Caputo, C Mussini, M Puoti, C F Perno, M Andreoni, A Ammassari, A Antinori, C Balotta, A Bandera, P Bonfanti, S Bonora, M Borderi, A Calcagno, L Calza, M R Capobianchi, A Castagna, F Ceccherini-Silberstein, A Cingolani, P Cinque, A Cozzi-Lepri, A d’Arminio Monforte, A De Luca, A Di Biagio, E Girardi, N Gianotti, A Gori, G Guaraldi, G Lapadula, M Lichtner, S Lo Caputo, G Madeddu, F Maggiolo, G Marchetti, S Marcotullio, L Monno, C Mussini, S Nozza, M Puoti, E Quiros Roldan, R Rossotti, S Rusconi, M M Santoro, A Saracino, M Zaccarelli, A Cozzi-Lepri, I Fanti, L Galli, P Lorenzini, A Rodano, M Shanyinde, A Tavelli, F Carletti, S Carrara, A Di Caro, S Graziano, F Petrone, G Prota, S Quartu, S Truffa, A Giacometti, A Costantini, V Barocci, G Angarano, L Monno, C Santoro, F Maggiolo, C Suardi, P Viale, V Donati, G Verucchi, F Castelli, C Minardi, E Quiros Roldan, T Quirino, C Abeli, P E Manconi, P Piano, B Cacopardo, B Celesia, J Vecchiet, K Falasca, L Sighinolfi, D Segala, P Blanc, F Vichi, G Cassola, C Viscoli, A Alessandrini, N Bobbio, G Mazzarello, C Mastroianni, I Pozzetto, P Bonfanti, C Molteni, A Chiodera, P Milini, G Nunnari, G Pellicanò, A d’Arminio Monforte, M Galli, A Lazzarin, G Rizzardini, M Puoti, A Castagna, G Marchetti, M C Moioli, R Piolini, A L Ridolfo, S Salpietro, C Tincati, C Mussini, C Puzzolante, A Gori, G Lapadula, A Chirianni, G Borgia, V Esposito, R Orlando, G Bonadies, F Di Martino, I Gentile, L Maddaloni, A M Cattelan, S Marinello, A Cascio, C Colomba, F Baldelli, E Schiaroli, G Parruti, F Sozio, G Magnani, M A Ursitti, M Andreoni, A Antinori, R Acinapura, G Baldin, M Capozzi, R Cauda, S Cicalini, A Cingolani, A Cristaudo, L Fontanelli Sulekova, G Iaiani, A Latini, I Mastrorosa, M M Plazzi, S Savinelli, A Vergori, V Vullo, M Cecchetto, F Viviani, G Madeddu, P Bagella, A De Luca, B Rossetti, A Franco, R Fontana Del Vecchio, D Francisci, C Di Giuli, P Caramello, G Di Perri, S Bonora, G C Orofino, M Sciandra, M Bassetti, A Londero, G Pellizzer, V Manfrin, G Starnini, A Ialungo Journal of Antimicrobial Chemotherapy, 2018
Procalcitonin is useful in driving the choice of early antibiotic treatment in patients with bloodstream infections European Review for Medical and Pharmacological Sciences, 2018
